GB0021649D0 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
GB0021649D0
GB0021649D0 GBGB0021649.9A GB0021649A GB0021649D0 GB 0021649 D0 GB0021649 D0 GB 0021649D0 GB 0021649 A GB0021649 A GB 0021649A GB 0021649 D0 GB0021649 D0 GB 0021649D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0021649.9A
Other versions
GB2367553A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Helmholtz Zentrum fuer Infektionsforschung HZI GmbH
Original Assignee
Novartis AG
Helmholtz Zentrum fuer Infektionsforschung HZI GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG, Helmholtz Zentrum fuer Infektionsforschung HZI GmbH filed Critical Novartis AG
Priority to GB0021649A priority Critical patent/GB2367553A/en
Publication of GB0021649D0 publication Critical patent/GB0021649D0/en
Publication of GB2367553A publication Critical patent/GB2367553A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB0021649A 2000-09-04 2000-09-04 Pharmaceutically Active Macrocycles Withdrawn GB2367553A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0021649A GB2367553A (en) 2000-09-04 2000-09-04 Pharmaceutically Active Macrocycles

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0021649A GB2367553A (en) 2000-09-04 2000-09-04 Pharmaceutically Active Macrocycles

Publications (2)

Publication Number Publication Date
GB0021649D0 true GB0021649D0 (en) 2000-10-18
GB2367553A GB2367553A (en) 2002-04-10

Family

ID=9898785

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0021649A Withdrawn GB2367553A (en) 2000-09-04 2000-09-04 Pharmaceutically Active Macrocycles

Country Status (1)

Country Link
GB (1) GB2367553A (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004093907A2 (en) * 2003-04-23 2004-11-04 Tomoaki Hoshino Therapeutic agents for treating dermatitis, alopecia and itching and transgenic animals for evaluating such therapeutic agents
EP1964560A1 (en) * 2007-02-28 2008-09-03 Helmholtz-Zentrum für Infektionsforschung GmbH Use of inhibitors of the degradation of p27 for the treatment of cancer
EP2138507A1 (en) * 2008-06-23 2009-12-30 Helmholtz-Zentrum für Infektionsforschung GmbH Method for producing intermediates for the production of novel macrocycles that are inhibitors of the proteasomic degradation of p27, such as argyrin and derivatives thereof, and uses of said macrocycles
JP5735977B2 (en) * 2009-12-14 2015-06-17 ヘルムホルツ−ツェントルム フュア インフェクツィオンスフォルシュンク ゲーエムベーハー Improved method for producing intermediates for the production of macrocycles such as argylin and its derivatives, which are inhibitors of p27 proteasome degradation

Also Published As

Publication number Publication date
GB2367553A (en) 2002-04-10

Similar Documents

Publication Publication Date Title
AU8389101A (en) Organic compounds
GB0010955D0 (en) Organic compounds
GB0006398D0 (en) Organic compounds
GB0003111D0 (en) Organic compounds
GB0008694D0 (en) Organic compounds
GB0001448D0 (en) Organic compounds
GB0008785D0 (en) Organic compounds
GB0002100D0 (en) Organic compounds
AU3458802A (en) Organic compounds
GB0007108D0 (en) Organic compounds
GB0007911D0 (en) Organic compounds
GB0002740D0 (en) Organic compounds
GB0021649D0 (en) Organic compounds
GB0009037D0 (en) Organic compounds
GB0009054D0 (en) Organic compounds
GB0010200D0 (en) Organic compounds
GB0009055D0 (en) Organic compounds
GB0009594D0 (en) Organic compounds
GB0010201D0 (en) Organic compounds
GB0007247D0 (en) Organic compounds
GB0007427D0 (en) Organic compounds
GB0007511D0 (en) Organic compounds
GB0002101D0 (en) Organic compounds
GB0002097D0 (en) Organic compounds
GB0006735D0 (en) Organic compounds

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)